Related Experiment Video
Updated: Aug 9, 2026

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
Strategic planning workshop on research needs for neutron capture therapy
1US Department of Energy, Office of Health and Environmental Research, Washington, DC, USA.
This workshop identified key research needs for Boron Neutron Capture Therapy (BNCT) to optimize current clinical trials for brain tumors and melanoma. Discussions focused on boron compounds, delivery, neutron irradiation, and dosimetry for improved cancer treatment.
Area of Science:
- Oncology
- Medical Physics
- Radiotherapy
Background:
- The 1995 workshop convened experts to address critical research gaps in Boron Neutron Capture Therapy (BNCT).
- Focus was placed on optimizing ongoing BNCT trials at Brookhaven National Laboratory (BNL) and Massachusetts Institute of Technology (MIT).
Framework:
- BNCT utilizes nuclear fission reactors as neutron sources for targeted cancer treatment.
- The therapy is being trialed for glioblastoma multiforme (BNL) and deep-seated melanoma (MIT).
Implementation:
- Discussions centered on identifying optimal boron-labeled compounds for brain tumors and their delivery methods.
- Key areas included optimizing neutron irradiation for precise dose delivery to tumor cells.
- Dosimetry challenges, particularly for brain applications, were thoroughly examined.
Implications:
- The workshop highlighted the need for tailored treatment protocols for various cancer types.
- Coordination across treatment sites and interdisciplinary cooperation among medical specialists are crucial for BNCT advancement.
- Future research directions were identified to enhance the efficacy and applicability of BNCT.
More Related Videos
10:27Contrast-Matching Detergent in Small-Angle Neutron Scattering Experiments for Membrane Protein Structural Analysis and Ab Initio Modeling
Published on: October 21, 2018
10:24Neutron Radiography and Computed Tomography of Biological Systems at the Oak Ridge National Laboratory's High Flux Isotope Reactor
Published on: May 7, 2021